APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Fractionation and Blood Product

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasma Fractionation and Blood Product Industry Growth and Trends Forecast to 2032

2 January 2026102 pages

Choose your research edition.

Industry ResearchPlasma Fractionation and Blood Product Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Fractionation and Blood Product Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Plasma Fractionation and Blood Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Fractionation and Blood Product Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Fractionation and Blood Product Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Plasma Fractionation and Blood Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasma Fractionation and Blood Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasma Fractionation and Blood Product include Takeda, RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols, CSL and CBPO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasma Fractionation and Blood Product market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasma Fractionation and Blood Product market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma Fractionation and Blood Product market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma Fractionation and Blood Product.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Plasma Fractionation and Blood Product market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasma Fractionation and Blood Product Market by Company

Takeda

RAAS

Octapharma

LFB Group

Kedrion

Hualan Bio

Grifols

CSL

CBPO

BPL

Biotest

Plasma Fractionation and Blood Product Segment by Type

Albumin

Immune Globulin

Coagulation Factor

Other

Plasma Fractionation and Blood Product Segment by Application

Immunology

Hematology

Other

Plasma Fractionation and Blood Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation and Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation and Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation and Blood Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Fractionation and Blood Product manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Plasma Fractionation and Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Albumin Table 2. Major Company of Immune Globulin Table 3. Major Company of Coagulation Factor Table 4. Major Company of Other Table 5. Global Plasma Fractionation and Blood Product Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 7. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Type (2021-2026) Table 8. Global Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 9. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Type (2021-2026) Table 10. Global Plasma Fractionation and Blood Product Price by Type (2021-2026) & (US$/Unit) Table 11. Global Plasma Fractionation and Blood Product Sales by Type (2027-2032) & (K Units) Table 12. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Type (2027-2032) Table 13. Global Plasma Fractionation and Blood Product Sales by Type (2027-2032) & (US$ Million) Table 14. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Type (2027-2032) Table 15. Global Plasma Fractionation and Blood Product Price by Type (2027-2032) & (US$/Unit) Table 16. North America Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 17. North America Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 19. Europe Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 23. Latin America Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2021-2026) & (US$ Million) Table 26. Plasma Fractionation and Blood Product Industry Trends Table 27. Plasma Fractionation and Blood Product Industry Drivers Table 28. Plasma Fractionation and Blood Product Industry Opportunities and Challenges Table 29. Plasma Fractionation and Blood Product Industry Restraints Table 30. Global Plasma Fractionation and Blood Product Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Plasma Fractionation and Blood Product Revenue Market Share by Company (2021-2026) Table 32. Global Plasma Fractionation and Blood Product Sales by Company (2021-2026) & (K Units) Table 33. Global Plasma Fractionation and Blood Product Sales Share by Company (2021-2026) Table 34. Global Plasma Fractionation and Blood Product Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Plasma Fractionation and Blood Product Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Plasma Fractionation and Blood Product Major Company Production Sites and Headquarters Table 37. Global Plasma Fractionation and Blood Product Company, Product Type & Application Table 38. Global Plasma Fractionation and Blood Product Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Plasma Fractionation and Blood Product Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Plasma Fractionation and Blood Product Sales by Region (2021-2026) & (K Units) Table 43. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Region (2021-2026) Table 44. Global Plasma Fractionation and Blood Product Sales by Region (2021-2026) & (US$ Million) Table 45. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Region (2021-2026) Table 46. Global Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Plasma Fractionation and Blood Product Sales by Region (2027-2032) & (K Units) Table 48. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Region (2027-2032) Table 49. Global Plasma Fractionation and Blood Product Sales by Region (2027-2032) & (US$ Million) Table 50. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Region (2027-2032) Table 51. Global Plasma Fractionation and Blood Product Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Plasma Fractionation and Blood Product Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 54. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Application (2021-2026) Table 55. Global Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 56. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Application (2021-2026) Table 57. Global Plasma Fractionation and Blood Product Price by Application (2021-2026) & (US$/Unit) Table 58. Global Plasma Fractionation and Blood Product Sales by Application (2027-2032) & (K Units) Table 59. Global Plasma Fractionation and Blood Product Sales Market Share in Volume by Application (2027-2032) Table 60. Global Plasma Fractionation and Blood Product Sales by Application (2027-2032) & (US$ Million) Table 61. Global Plasma Fractionation and Blood Product Sales Market Share in Value by Application (2027-2032) Table 62. Global Plasma Fractionation and Blood Product Price by Application (2027-2032) & (US$/Unit) Table 63. North America Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 64. North America Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 66. Europe Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 70. Latin America Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takeda Plasma Fractionation and Blood Product Product Portfolio Table 77. Takeda Recent Development Table 78. RAAS Company Information Table 79. RAAS Business Overview Table 80. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. RAAS Plasma Fractionation and Blood Product Product Portfolio Table 82. RAAS Recent Development Table 83. Octapharma Company Information Table 84. Octapharma Business Overview Table 85. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Octapharma Plasma Fractionation and Blood Product Product Portfolio Table 87. Octapharma Recent Development Table 88. LFB Group Company Information Table 89. LFB Group Business Overview Table 90. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. LFB Group Plasma Fractionation and Blood Product Product Portfolio Table 92. LFB Group Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Kedrion Plasma Fractionation and Blood Product Product Portfolio Table 97. Kedrion Recent Development Table 98. Hualan Bio Company Information Table 99. Hualan Bio Business Overview Table 100. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hualan Bio Plasma Fractionation and Blood Product Product Portfolio Table 102. Hualan Bio Recent Development Table 103. Grifols Company Information Table 104. Grifols Business Overview Table 105. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Grifols Plasma Fractionation and Blood Product Product Portfolio Table 107. Grifols Recent Development Table 108. CSL Company Information Table 109. CSL Business Overview Table 110. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. CSL Plasma Fractionation and Blood Product Product Portfolio Table 112. CSL Recent Development Table 113. CBPO Company Information Table 114. CBPO Business Overview Table 115. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. CBPO Plasma Fractionation and Blood Product Product Portfolio Table 117. CBPO Recent Development Table 118. BPL Company Information Table 119. BPL Business Overview Table 120. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. BPL Plasma Fractionation and Blood Product Product Portfolio Table 122. BPL Recent Development Table 123. Biotest Company Information Table 124. Biotest Business Overview Table 125. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Biotest Plasma Fractionation and Blood Product Product Portfolio Table 127. Biotest Recent Development Table 128. North America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. North America Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 130. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 131. North America Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032) & (K Units) Table 132. North America Plasma Fractionation and Blood Product Sales Market Share Forecast by Country (2027-2032) Table 133. North America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Plasma Fractionation and Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Plasma Fractionation and Blood Product Market Share by Country (2021-2026) Table 136. North America Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Plasma Fractionation and Blood Product Market Share Forecast by Country (2027-2032) Table 138. Europe Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Europe Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 140. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 141. Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032) & (K Units) Table 142. Europe Plasma Fractionation and Blood Product Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Plasma Fractionation and Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Plasma Fractionation and Blood Product Market Share by Country (2021-2026) Table 146. Europe Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Plasma Fractionation and Blood Product Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 150. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032) & (K Units) Table 152. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Plasma Fractionation and Blood Product Market Share by Country (2021-2026) Table 156. Asia-Pacific Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Plasma Fractionation and Blood Product Market Share Forecast by Country (2027-2032) Table 158. Latin America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Latin America Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 160. Latin America Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 161. Latin America Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032) & (K Units) Table 162. Latin America Plasma Fractionation and Blood Product Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Plasma Fractionation and Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Plasma Fractionation and Blood Product Market Share by Country (2021-2026) Table 166. Latin America Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Plasma Fractionation and Blood Product Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2026) & (K Units) Table 170. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032) & (K Units) Table 172. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Plasma Fractionation and Blood Product Market Share by Country (2021-2026) Table 176. Middle East and Africa Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Plasma Fractionation and Blood Product Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Plasma Fractionation and Blood Product Distributors List Table 181. Plasma Fractionation and Blood Product Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Plasma Fractionation and Blood Product Image Figure 2. Global Plasma Fractionation and Blood Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Fractionation and Blood Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Fractionation and Blood Product Sales (2021-2032) & (K Units) Figure 5. Albumin Image Figure 6. Global Albumin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Immune Globulin Image Figure 8. Global Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Coagulation Factor Image Figure 10. Global Coagulation Factor Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Plasma Fractionation and Blood Product Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Plasma Fractionation and Blood Product Market Share by Type 2025 VS 2032 Figure 15. North America Plasma Fractionation and Blood Product Sales Market Share in Volume by Type in 2025 Figure 16. North America Plasma Fractionation and Blood Product Sales Market Share in Value by Type in 2025 Figure 17. Europe Plasma Fractionation and Blood Product Sales Market Share in Volume by Type in 2025 Figure 18. Europe Plasma Fractionation and Blood Product Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share in Value by Type in 2025 Figure 21. Latin America Plasma Fractionation and Blood Product Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Plasma Fractionation and Blood Product Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Plasma Fractionation and Blood Product Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Immunology Image Figure 28. Global Immunology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hematology Image Figure 30. Global Hematology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Plasma Fractionation and Blood Product Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Plasma Fractionation and Blood Product Market Share by Application 2025 VS 2032 Figure 35. North America Plasma Fractionation and Blood Product Sales Market Share in Volume by Application in 2025 Figure 36. North America Plasma Fractionation and Blood Product Sales Market Share in Value by Application in 2025 Figure 37. Europe Plasma Fractionation and Blood Product Sales Market Share in Volume by Application in 2025 Figure 38. Europe Plasma Fractionation and Blood Product Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share in Value by Application in 2025 Figure 41. Latin America Plasma Fractionation and Blood Product Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Plasma Fractionation and Blood Product Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share in Value by Application in 2025 Figure 45. North America Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Plasma Fractionation and Blood Product Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Plasma Fractionation and Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Plasma Fractionation and Blood Product Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Plasma Fractionation and Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Plasma Fractionation and Blood Product Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Plasma Fractionation and Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Plasma Fractionation and Blood Product Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Plasma Fractionation and Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Plasma Fractionation and Blood Product Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Plasma Fractionation and Blood Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Plasma Fractionation and Blood Product Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Plasma Fractionation and Blood Product Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Other
Applications
  • Immunology
  • Hematology
  • Other
Companies covered
  • Takeda
  • RAAS
  • Octapharma
  • LFB Group
  • Kedrion
  • Hualan Bio
  • Grifols
  • CSL
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasma Fractionation and Blood Product Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Plasma Fractionation and Blood Product Market by Type
  6. 1.3.1 Albumin
  7. 1.3.2 Immune Globulin
  8. 1.3.3 Coagulation Factor
  9. 1.3.4 Other
  10. 1.4 Global Plasma Fractionation and Blood Product Market Size by Type
  11. 1.4.1 Global Plasma Fractionation and Blood Product Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Plasma Fractionation and Blood Product Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Plasma Fractionation and Blood Product Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Plasma Fractionation and Blood Product Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Plasma Fractionation and Blood Product Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Plasma Fractionation and Blood Product Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Plasma Fractionation and Blood Product Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Plasma Fractionation and Blood Product Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Plasma Fractionation and Blood Product Industry Trends
  2. 2.2 Plasma Fractionation and Blood Product Industry Drivers
  3. 2.3 Plasma Fractionation and Blood Product Industry Opportunities and Challenges
  4. 2.4 Plasma Fractionation and Blood Product Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Plasma Fractionation and Blood Product Revenue (2021-2026)
  2. 3.2 Global Top Players by Plasma Fractionation and Blood Product Sales (2021-2026)
  3. 3.3 Global Top Players by Plasma Fractionation and Blood Product Price (2021-2026)
  4. 3.4 Global Plasma Fractionation and Blood Product Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Fractionation and Blood Product Major Company Production Sites & Headquarters
  6. 3.6 Global Plasma Fractionation and Blood Product Company, Product Type & Application
  7. 3.7 Global Plasma Fractionation and Blood Product Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Fractionation and Blood Product Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Fractionation and Blood Product Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Fractionation and Blood Product Tier 1, Tier 2, and Tier 3
4 Plasma Fractionation and Blood Product Regional Status and Outlook
  1. 4.1 Global Plasma Fractionation and Blood Product Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Plasma Fractionation and Blood Product Historic Market Size by Region
  3. 4.2.1 Global Plasma Fractionation and Blood Product Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Plasma Fractionation and Blood Product Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Plasma Fractionation and Blood Product Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Plasma Fractionation and Blood Product Forecasted Market Size by Region
  7. 4.3.1 Global Plasma Fractionation and Blood Product Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Plasma Fractionation and Blood Product Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Plasma Fractionation and Blood Product Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasma Fractionation and Blood Product by Application
  1. 5.1 Plasma Fractionation and Blood Product Market by Application
  2. 5.1.1 Immunology
  3. 5.1.2 Hematology
  4. 5.1.3 Other
  5. 5.2 Global Plasma Fractionation and Blood Product Market Size by Application
  6. 5.2.1 Global Plasma Fractionation and Blood Product Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Plasma Fractionation and Blood Product Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Plasma Fractionation and Blood Product Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Plasma Fractionation and Blood Product Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Plasma Fractionation and Blood Product Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Plasma Fractionation and Blood Product Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Plasma Fractionation and Blood Product Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Plasma Fractionation and Blood Product Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Plasma Fractionation and Blood Product Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 RAAS
  8. 6.2.1 RAAS Company Information
  9. 6.2.2 RAAS Business Overview
  10. 6.2.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 RAAS Plasma Fractionation and Blood Product Product Portfolio
  12. 6.2.5 RAAS Recent Developments
  13. 6.3 Octapharma
  14. 6.3.1 Octapharma Company Information
  15. 6.3.2 Octapharma Business Overview
  16. 6.3.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Octapharma Plasma Fractionation and Blood Product Product Portfolio
  18. 6.3.5 Octapharma Recent Developments
  19. 6.4 LFB Group
  20. 6.4.1 LFB Group Company Information
  21. 6.4.2 LFB Group Business Overview
  22. 6.4.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LFB Group Plasma Fractionation and Blood Product Product Portfolio
  24. 6.4.5 LFB Group Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Plasma Fractionation and Blood Product Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 Hualan Bio
  32. 6.6.1 Hualan Bio Company Information
  33. 6.6.2 Hualan Bio Business Overview
  34. 6.6.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hualan Bio Plasma Fractionation and Blood Product Product Portfolio
  36. 6.6.5 Hualan Bio Recent Developments
  37. 6.7 Grifols
  38. 6.7.1 Grifols Company Information
  39. 6.7.2 Grifols Business Overview
  40. 6.7.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Grifols Plasma Fractionation and Blood Product Product Portfolio
  42. 6.7.5 Grifols Recent Developments
  43. 6.8 CSL
  44. 6.8.1 CSL Company Information
  45. 6.8.2 CSL Business Overview
  46. 6.8.3 CSL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSL Plasma Fractionation and Blood Product Product Portfolio
  48. 6.8.5 CSL Recent Developments
  49. 6.9 CBPO
  50. 6.9.1 CBPO Company Information
  51. 6.9.2 CBPO Business Overview
  52. 6.9.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CBPO Plasma Fractionation and Blood Product Product Portfolio
  54. 6.9.5 CBPO Recent Developments
  55. 6.10 BPL
  56. 6.10.1 BPL Company Information
  57. 6.10.2 BPL Business Overview
  58. 6.10.3 BPL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 BPL Plasma Fractionation and Blood Product Product Portfolio
  60. 6.10.5 BPL Recent Developments
  61. 6.11 Biotest
  62. 6.11.1 Biotest Company Information
  63. 6.11.2 Biotest Business Overview
  64. 6.11.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biotest Plasma Fractionation and Blood Product Product Portfolio
  66. 6.11.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America Plasma Fractionation and Blood Product Sales by Country
  2. 7.1.1 North America Plasma Fractionation and Blood Product Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  4. 7.1.3 North America Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032)
  5. 7.2 North America Plasma Fractionation and Blood Product Market Size by Country
  6. 7.2.1 North America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Plasma Fractionation and Blood Product Market Size by Country (2021-2026)
  8. 7.2.3 North America Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Plasma Fractionation and Blood Product Sales by Country
  2. 8.1.1 Europe Plasma Fractionation and Blood Product Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  4. 8.1.3 Europe Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Plasma Fractionation and Blood Product Market Size by Country
  6. 8.2.1 Europe Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Plasma Fractionation and Blood Product Market Size by Country (2021-2026)
  8. 8.2.3 Europe Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Plasma Fractionation and Blood Product Sales by Country
  2. 9.1.1 Asia-Pacific Plasma Fractionation and Blood Product Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country
  6. 9.2.1 Asia-Pacific Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Plasma Fractionation and Blood Product Sales by Country
  2. 10.1.1 South America Plasma Fractionation and Blood Product Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  4. 10.1.3 South America Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032)
  5. 10.2 South America Plasma Fractionation and Blood Product Market Size by Country
  6. 10.2.1 South America Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Plasma Fractionation and Blood Product Market Size by Country (2021-2026)
  8. 10.2.3 South America Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country
  2. 11.1.1 Middle East and Africa Plasma Fractionation and Blood Product Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Plasma Fractionation and Blood Product Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country
  6. 11.2.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Plasma Fractionation and Blood Product Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Plasma Fractionation and Blood Product Value Chain Analysis
  2. 12.1.1 Plasma Fractionation and Blood Product Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Plasma Fractionation and Blood Product Production Mode & Process
  7. 12.2 Plasma Fractionation and Blood Product Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Plasma Fractionation and Blood Product Distributors
  10. 12.2.3 Plasma Fractionation and Blood Product Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst